Sophie De Carne Trecesson

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Journal: Nature
Published: January 14, 2026

KRAS Inhibitor-Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.

KRAS Inhibitor-Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.

Journal: Cancer research
Published: December 12, 2025

Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

Journal: Cancer discovery
Published: May 21, 2025

Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.

Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.

Journal: Nature cancer
Published: January 31, 2024

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade.

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade.

Journal: Nature communications
Published: January 23, 2024

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.

CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.

Journal: Cancer research
Published: August 30, 2023

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

Journal: Nature genetics
Published: June 25, 2023

Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Journal: Nature
Published: March 07, 2022

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.

Journal: Cancer research
Published: January 28, 2022

Genomic-transcriptomic evolution in lung cancer and metastasis.

Genomic-transcriptomic evolution in lung cancer and metastasis.

Journal: Nature
Published: October 21, 2021

RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma.

RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma.

Journal: Nature communications
Published: May 26, 2021

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.

Journal: Immunity
Published: October 14, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026